The Food and Drugs Authority (FDA) has hosted a landmark Pan-African Vaccine Regulatory Workshop in partnership with PTB, the Paul-Ehrlich-Institute, and GIZ — bringing together regulatory authorities from eight WHO Maturity Level 3 qualified African countries: Egypt, Ghana, Nigeria, Rwanda, Senegal, South Africa, Tanzania, and Zimbabwe.

A Shared Agenda for Africa’s Vaccine Security

The workshop centred on regional collaboration and reliance in Vaccine Lot Release Best Practices, with a clear overarching goal: ensuring consistent product availability and the uninterrupted supply of vaccines across the continent. As vaccine access remains a critical pillar of Africa’s health security, the convening underscored the importance of harmonised regulatory standards and shared technical capacity among African nations.

Two Days of Knowledge Exchange and Hands-On Engagement

The first day was dedicated to in-depth knowledge sharing and technical discussions among participating regulators, providing a platform to exchange insights, identify common challenges, and align approaches to vaccine regulation across the region.

On the second day, the FDA welcomed an 18-member delegation for a programme hosted at its headquarters. The day opened with a formal Opening Ceremony at the FDA Boardroom, followed by a guided tour of the FDA Laboratory — offering delegates a firsthand look at Ghana’s regulatory infrastructure, technical capabilities, and commitment to scientific excellence.

Ghana as a Hub for African Regulatory Excellence

The successful hosting of this workshop reinforces Ghana’s standing as a leader in regulatory science on the continent. The FDA reaffirms its commitment to fostering regional collaboration and technical solidarity in support of vaccine safety and availability — not just for Ghana, but for all of Africa.